A global polio resurgence and the need to reevaluate the basics
Context: Polio, a near-eradicated disease, has resurfaced in various regions, with detections of both wild poliovirus (WPV) and vaccine-derived poliovirus (VDPV). This resurgence calls for a reassessment of eradication strategies and vaccine choices to sustain global progress. Relevance : GS 2(Health ) Resurgence in Developed and Developing Nations: Polio Vaccination Dilemma: Transmission Dynamics – Faecal-Oral vs. Respiratory: Global Polio Eradication Initiative (GPEI): […]
Unacceptable Failures in Implementing Patient Safety Protocol
Relevance : GS 2(Health )
Disease X: Preparedness and Global Significance
What is Disease X? Relevance : GS 2(Health) Current Concerns: Challenges in Prediction: Preparation Strategies:
India Accounts For Half of Malaria Cases In Southeast Asia in 2023
Background: WHO released World Malaria Report 2024. Relevance: GS 2 ( Health). Malaria Burden: Reduction in Deaths: Progress Since 2000:
Ayush Visa and e-Ayush Visa
Context: Relevance: GS 2 (Health) Ayush Visa: Four Sub-Categories:
India Used 114 mg of Antibiotics For Every KG of Meat in 2020
Background: Antibiotics save lives but their overuse, especially in livestock, leads to antibiotic-resistant bacteria, threatening both animal and human health. Relevance: GS 2( Health)
Tuberculosis and Mental Health
Relevance: GS-2 (Health)
New HIV Infections Declined 44% in 2023
Relevance : GS 2 ( Health )
About Sjögren’s Disease
Context: Experts say that Sjogren’s disease in India is a silent epidemic, underdiagnosed and poorly understood. Relevance: GS II: Health About Sjögren’s disease: Sjögren’s disease is an autoimmune condition characterized by the immune system’s attack on the body’s moisture-producing glands. Here are some essential details about this disorder: -Source: The Hindu
2024 Index Report Assesses Pharmaceutical Efforts in Expanding Access to Medicine
Context: The Access to Medicine Foundation recently released its 2024 Index Report, which evaluates the efforts of pharmaceutical companies to improve access to medicines in low and middle-income countries (LMICs). This assessment highlights the various strategies and initiatives pharmaceutical companies are undertaking to address health care disparities despite persistent challenges. Relevance: GS II: Health Dimensions […]